Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.7950
-0.0750 (-8.62%)
Oct 1, 2026, 4:10 PM AEST
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 414.86 million as of October 1, 2026. Its market cap has increased by 350.89% in one year.
Market Cap
414.86M
Enterprise Value
404.55M
Revenue
12.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.80
ChartMarket Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 414.86M, an increase of 729.72%. That is a compound annual growth rate of 8.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 414.86M | 175.54% |
| Dec 31, 2025 | 150.56M | 227.36% |
| Dec 31, 2024 | 45.99M | -34.30% |
| Dec 29, 2023 | 70.01M | -68.87% |
| Dec 30, 2022 | 224.87M | -58.74% |
| Dec 31, 2021 | 544.95M | -14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 787.20M |
| Clinuvel Pharmaceuticals | 412.00M |
| Racura Oncology | 378.41M |
| Tetratherix | 314.11M |
| Actinogen Medical | 230.87M |
| BLS Pharmaceuticals | 229.15M |
| Orthocell | 202.89M |
| Paradigm Biopharmaceuticals | 146.80M |